Combined Hangzhou criteria with neutrophil-lymphocyte ratio is superior to other criteria in selecting liver transplantation candidates with HBV-related hepatocellular carcinoma

Hepatobiliary and Pancreatic Diseases International

Volumn 14, Issue 6, 2015, Pages 588-595

  Xiao, Guang Qin ^a,b   Yang, Jia Yin ^a   Yan, Lu Nan ^a  

^a SICHUAN UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

biomarker; Hangzhou criteria; hepatitis B virus; hepatocellular carcinoma; liver transplantation; neutrophil lymphocyte ratio

Indexed keywords

ALPHA FETOPROTEIN; AFP PROTEIN, HUMAN;

ADULT; ALPHA FETOPROTEIN BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; CANCER CLASSIFICATION; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HANGZHOU CRITERIA; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL LYMPHOCYTE RATIO; OVERALL SURVIVAL; PATIENT SELECTION; POSTOPERATIVE PERIOD; RECURRENCE FREE SURVIVAL; SURGICAL RISK; TREATMENT OUTCOME; TUMOR INVASION; ADVERSE EFFECTS; BLOOD; CARCINOMA, HEPATOCELLULAR; CHI SQUARE DISTRIBUTION; COMPLICATION; DECISION SUPPORT SYSTEM; DISEASE COURSE; DISEASE FREE SURVIVAL; FEASIBILITY STUDY; HEPATITIS B; KAPLAN MEIER METHOD; LIVER NEOPLASMS; LYMPHOCYTE; LYMPHOCYTE COUNT; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NEUTROPHIL; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; RECEIVER OPERATING CHARACTERISTIC; REGISTER; REPRODUCIBILITY; RETROSPECTIVE STUDY; RISK FACTOR; TIME FACTOR; TUMOR RECURRENCE; TUMOR VOLUME; VALIDATION STUDY; VIROLOGY;

ALPHA-FETOPROTEINS; AREA UNDER CURVE; CARCINOMA, HEPATOCELLULAR; CHI-SQUARE DISTRIBUTION; DECISION SUPPORT TECHNIQUES; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEASIBILITY STUDIES; FEMALE; HEPATITIS B; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEUTROPHILS; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; TIME FACTORS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84951744883     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-3872(15)60416-7     Document Type: Article

References (38)

1. A Forner, JM Llovet, J Bruix Hepatocellular carcinoma Lancet 379 2012 1245 1255
2. A Jemal, F Bray, MM Center, J Ferlay, E Ward, D Forman Global cancer statistics CA Cancer J Clin 61 2011 69 90
3. V Mazzaferro, E Regalia, R Doci, S Andreola, A Pulvirenti, F Bozzetti et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 1996 693 699
4. FY Yao, L Ferrell, NM Bass, JJ Watson, P Bacchetti, A Venook et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival Hepatology 33 2001 1394 1403
5. SS Zheng, X Xu, J Wu, J Chen, WL Wang, M Zhang et al. Liver transplantation for hepatocellular carcinoma: Hangzhou experiences Transplantation 85 2008 1726 1732
6. S Jonas, WO Bechstein, T Steinmüller, M Herrmann, C Radke, T Berg et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis Hepatology 33 2001 1080 1086
7. M Sherman Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis Semin Liver Dis 30 2010 3 16
8. LM Coussens, Z Werb Inflammation and cancer Nature 420 2002 860 867
9. A Mantovani, P Allavena, A Sica, F Balkwill Cancer-related inflammation Nature 454 2008 436 444
10. BS Oh, JW Jang, JH Kwon, CR You, KW Chung, CS Kay et al. Prognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma BMC Cancer 13 2013 78
11. Y Mano, K Shirabe, Y Yamashita, N Harimoto, E Tsujita, K Takeishi et al. Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis Ann Surg 258 2013 301 305
12. SJ Fu, SL Shen, SQ Li, YP Hua, WJ Hu, LJ Liang et al. Prognostic value of preoperative peripheral neutrophil-to-lymphocyte ratio in patients with HBV-associated hepatocellular carcinoma after radical hepatectomy Med Oncol 30 2013 721
13. D Gomez, S Farid, HZ Malik, AL Young, GJ Toogood, JP Lodge et al. Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma World J Surg 32 2008 1757 1762
14. KJ Halazun, MA Hardy, AA Rana, DC Woodland 4th, EJ Luyten, S Mahadev et al. Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma Ann Surg 250 2009 141 151
15. AR Limaye, V Clark, C Soldevila-Pico, G Morelli, A Suman, R Firpi et al. Neutrophil-lymphocyte ratio predicts overall and recurrence-free survival after liver transplantation for hepatocellular carcinoma Hepatol Res 43 2013 757 764
16. T Yoshizumi, T Ikegami, S Yoshiya, T Motomura, Y Mano, J Muto et al. Impact of tumor size, number of tumors and neutrophil-to-lymphocyte ratio in liver transplantation for recurrent hepatocellular carcinoma Hepatol Res 43 2013 709 716
17. VR Bertuzzo, M Cescon, M Ravaioli, GL Grazi, G Ercolani, M Del Gaudio et al. Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers Transplantation 91 2011 1279 1285
18. GY Wang, Y Yang, Q Zhang, H Li, GZ Chen, SH Yi et al. Preoperative neutrophil-lymphocyte ratio as a prognostic predictor after liver transplantation for hepatocellular carcinoma Zhonghua Yi Xue Za Zhi 91 2011 1519 1522
19. J Lei, L Yan Outcome comparisons among the Hangzhou, Chengdu, and UCSF criteria for hepatocellular carcinoma liver transplantation after successful downstaging therapies J Gastrointest Surg 17 2013 1116 1122
20. T Gao, Q Xia, K Qiu de, YY Feng, JC Chi, SY Wang et al. Comparison of survival and tumor recurrence rates in patients undergoing liver transplantation for hepatitis B-related hepatocellular carcinoma using Milan, Shanghai Fudan and Hangzhou criteria J Dig Dis 14 2013 552 558
21. L Jiang, LN Yan Current therapeutic strategies for recurrent hepatitis B virus infection after liver transplantation World J Gastroenterol 16 2010 2468 2475
22. S Iwatsuki, JW Marsh, TE Starzl Survival after liver transplantation in patients with hepatocellular carcinoma Princess Takamatsu Symp 25 1995 271 276
23. R Selby, Z Kadry, B Carr, A Tzakis, JR Madariaga, S Iwatsuki Liver transplantation for hepatocellular carcinoma World J Surg 19 1995 53 58
24. JM Kim, CH Kwon, JW Joh, SJ Kim, M Shin, EY Kim et al. Patients with unresectable hepatocellular carcinoma beyond Milan criteria: should we perform transarterial chemoembolization or liver transplantation? Transplant Proc 42 2010 821 824
25. JY Lei, WT Wang, LN Yan Hangzhou criteria for liver transplantation in hepatocellular carcinoma: a single-center experience Eur J Gastroenterol Hepatol 26 2014 200 204
26. M Silva, A Moya, M Berenguer, F Sanjuan, R López-Andujar, E Pareja et al. Expanded criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma Liver Transpl 14 2008 1449 1460
27. ZL Huang, J Luo, MS Chen, JQ Li, M Shi Blood neutrophil-to-lymphocyte ratio predicts survival in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization J Vasc Interv Radiol 22 2011 702 709
28. TM Chen, CC Lin, PT Huang, CF Wen Neutrophil-to-lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation J Gastroenterol Hepatol 27 2012 553 561
29. Q Lai, E Castro Santa, JM Rico Juri, RS Pinheiro, J Lerut Neutrophil and platelet-to-lymphocyte ratio as new predictors of dropout and recurrence after liver transplantation for hepatocellular cancer Transpl Int 27 2014 32 41
30. GY Wang, Y Yang, H Li, J Zhang, N Jiang, MR Li et al. A scoring model based on neutrophil to lymphocyte ratio predicts recurrence of HBV-associated hepatocellular carcinoma after liver transplantation PLoS One 6 2011 e25295
31. Q Zhang, X Chen, Y Zang, L Zhang, H Chen, L Wang et al. The survival benefit of liver transplantation for hepatocellular carcinoma patients with hepatitis B virus infection and cirrhosis PLoS One 7 2012 e50919
32. SV Brodsky, N Mendelev, M Melamed, G Ramaswamy Vascular density and VEGF expression in hepatic lesions J Gastrointestin Liver Dis 16 2007 373 377
33. K Araki, F Kishihara, K Takahashi, T Matsumata, T Shimura, T Suehiro et al. Hepatocellular carcinoma producing a granulocyte colony-stimulating factor: report of a resected case with a literature review Liver Int 27 2007 716 721
34. T Motomura, K Shirabe, Y Mano, J Muto, T Toshima, Y Umemoto et al. Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment J Hepatol 58 2013 58 64
35. XD Zhu, JB Zhang, PY Zhuang, HG Zhu, W Zhang, YQ Xiong et al. High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma J Clin Oncol 26 2008 2707 2716
36. E Unitt, A Marshall, W Gelson, SM Rushbrook, S Davies, SL Vowler et al. Tumour lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantation J Hepatol 45 2006 246 253
37. HS Kim, KH Han, HH Chung, JW Kim, NH Park, YS Song et al. Neutrophil to lymphocyte ratio for preoperative diagnosis of uterine sarcomas: a case-matched comparison Eur J Surg Oncol 36 2010 691 698
38. L Graziosi, E Marino, V De Angelis, A Rebonato, E Cavazzoni, A Donini Prognostic value of preoperative neutrophils to lymphocytes ratio in patients resected for gastric cancer Am J Surg 209 2015 333 337